<DOC>
	<DOCNO>NCT01491373</DOCNO>
	<brief_summary>This study design evaluate feasibility recombinant human bone morphogenetic protein-2 absorbable collagen sponge taper interbody fusion device ( LT-CAGE® ) anterior lumbar interbody fusion patient degenerative disc disease .</brief_summary>
	<brief_title>Pilot Study rhBMP-2/ACS/LT-CAGE® Anterior Lumbar Interbody Fusion Patients With Degenerative Disc Disease</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . Has degenerative disc disease note back pain discogenic origin degeneration disc confirm radiographic study . 2 . Has great Grade 1 spondylolisthesis utilize Meyerding 's Classification ( Meyerding HW , 1932 . ) 3 . Has single level symptomatic degenerative involvement L2 S1 . 4 . Is ages 18 65 , inclusive , time surgery . 5 . Is willing comply study plan sign Patient Informed Consent Form . 6 . Has respond conservative treatment period 5 month . 7 . If childbearing potential , subject nonpregnant ( document negative Pregnancy test within 72 hour surgery ) , nonnursing female agrees use adequate contraception 16 week follow surgery 1 . Has spinal condition symptomatic degenerative disc disease involve surgical level . 2 . Had previous anterior surgical procedure involve spinal level . 3 . Has condition require postoperative medication interfere fusion steroid nonsteroidal antiinflammatory drug . ( This include low dose aspirin prophylactic anticoagulation . ) 4 . Has osteopenia , osteoporosis , osteomalacia degree spinal instrumentation would contraindicate . 5 . Has circulatory problem , thrombophlebitis , lymphedema , vascular deficiency implant site . 6 . Has symptomatic cardiac disease . 7 . Has presence active malignancy history cancer past 5 year . 8 . Has overt active infection . 9 . Is obese , i.e. , weight great 40 % ideal age height . 10 . Has fever ( temperature &gt; 101°F oral ) . 11 . Has local inflammatory sign indicative infection . 12 . Has document metal allergy intolerance . 13 . Is involved worker 's compensation unresolved spinal litigation case . 14 . Is mentally incompetent ( either document opinion investigator ) . 15 . Has psychogenic magnification pain ( opinion investigator ) . 16 . Is prisoner . 17 . Is pregnant . 18 . Is alcohol and/or substance abuser . 19 . Requires bone growth stimulation lumbar spine . 20 . Is tobacco user time surgery . 21 . Patient receive drug may interfere bone metabolism within two week prior plan date spinal fusion surgery ( e.g. , steroids methotrexate ) . 22 . Patient history autoimmune disease ( systemic lupus erythematosus dermatomyositis ) . 23 . The subject history exposure injectable collagen implant . 24 . Patient 's history include hypersensitivity protein pharmaceutical ( monoclonal antibody gamma globulin ) collagen . 25 . Patient receive treatment investigational therapy within 28 day prior implantation surgery treatment plan 16 week follow rhBMP2/ACS implantation . 26 . Patient receive previous exposure BMP . 27 . The patient require allograft bone substitute part treatment . 28 . Patient history endocrine metabolic disorder know affect osteogenesis ( e.g . Paget 's disease , renal osteodystrophy , EhlersDanlos syndrome , osteogenesis imperfecta ) . 29 . Patient physician 's opinion , would good candidate surgical procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Degenerative Disc Disease</keyword>
	<keyword>Symptomatic Degenerative Disc Disease</keyword>
</DOC>